Macroscopic Characteristics of the Native Liver in Children With MPV17‐Related Mitochondrial DNA Depletion Syndrome: An Indication for Performing Liver Transplantation?

Mureo Kasahara, Seisuke Sakamoto, Akinari Fukuda, Reiko Horikawa, Reiko Ito, Hajime Uchida, Yusuke Yanagi, Seiichi Shimizu, Toshimasa Nakao, Kotaro Mimori, Chizuko Haga, Andrea Schlegel, Akira Ohtake, Masaru Shimura, Takuya Fushimi, Keiko Ichimoto, Ayako Matsunaga, Kei Murayama – 17 September 2021

Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation

Seak Hee Oh, In Sook Jeong, Dae Yeon Kim, Jung‐Man Namgoong, Won Kyoung Jhang, Seong Jong Park, Dong‐Hwan Jung, Deok Bog Moon, Gi‐Won Song, Gil‐Chun Park, Tae‐Yong Ha, Chul‐Soo Ahn, Ki‐Hun Kim, Shin Hwang, Sung Gyu Lee, Kyung Mo Kim – 17 September 2021 – Living donor liver transplantation (LDLT) is a significant advancement for the treatment of children with end‐stage liver disease given the shortage of deceased donors. The ultimate goal of pediatric LDLT is to achieve complete donor safety and zero recipient mortality.

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance

Nia Adeniji, Renumathy Dhanasekaran – 16 September 2021 – Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide. Early detection of HCC enables patients to avail curative therapies that can improve patient survival. Current international guidelines advocate for the enrollment of patients at high risk for HCC, like those with cirrhosis, in surveillance programs that perform ultrasound every 6 months.

Subscribe to